Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

FHS
July 23, 2024
9:04 am

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

Using Network Data to Improve the Performance & Security of Clinical Apps

Eileen Haggerty, Area VP, Product and Solutions Marketing, NETSCOUT From diagnosis to prescription, each facet of healthcare delivery hinges on the reliability of digital infrastructure

June 20, 2024

ICR to enter AI-powered cancer drug discovery partnership

KRAS-mutated cancer cells. Credit Lisa Pickard / Louise Howell / ICR. Scientists at the Institute of Cancer Research (ICR) London are set to enter a partnership

July 13, 2023

Across two clinical trials, gene therapy restores hearing in children deaf since birth: #ASGCT24

BALTIMORE — Ten out of 11 children who were born deaf can now hear after receiving a gene therapy from a Shanghai biotech, according to

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.